clofibric acid has been researched along with Hyperhomocysteinemia in 2 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
Hyperhomocysteinemia: Condition in which the plasma levels of homocysteine and related metabolites are elevated (
| Excerpt | Relevance | Reference |
|---|---|---|
| "To test the hypothesis that endothelial dysfunction in hyperhomocysteinemia was due to increased levels of nitrotyrosine and matrix metalloproteinase (MMP) activity in response to antagonism of peroxisome proliferator-activated receptor-alpha (PPAR-alpha), cystathionine beta-synthase (CBS) -/+ mice were bred, tail tissue was analyzed for genotype by PCR, and tail vein blood was analyzed for homocysteine (Hcy) by spectrofluorometry." | 7.72 | Peroxisome proliferator ameliorates endothelial dysfunction in a murine model of hyperhomocysteinemia. ( Hunt, MJ; Sood, HS; Tyagi, SC, 2003) |
| "To test the hypothesis that endothelial dysfunction in hyperhomocysteinemia was due to increased levels of nitrotyrosine and matrix metalloproteinase (MMP) activity in response to antagonism of peroxisome proliferator-activated receptor-alpha (PPAR-alpha), cystathionine beta-synthase (CBS) -/+ mice were bred, tail tissue was analyzed for genotype by PCR, and tail vein blood was analyzed for homocysteine (Hcy) by spectrofluorometry." | 3.72 | Peroxisome proliferator ameliorates endothelial dysfunction in a murine model of hyperhomocysteinemia. ( Hunt, MJ; Sood, HS; Tyagi, SC, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sood, HS | 1 |
| Hunt, MJ | 1 |
| Tyagi, SC | 1 |
| Lacut, K | 1 |
| Le Gal, G | 1 |
| Abalain, JH | 1 |
| Mottier, D | 1 |
| Oger, E | 1 |
2 other studies available for clofibric acid and Hyperhomocysteinemia
| Article | Year |
|---|---|
Peroxisome proliferator ameliorates endothelial dysfunction in a murine model of hyperhomocysteinemia.
Topics: Animals; Aorta; Blood Pressure; Clofibric Acid; Cystathionine beta-Synthase; Endothelium, Vascular; | 2003 |
Differential associations between lipid-lowering drugs, statins and fibrates, and venous thromboembolism: role of drug induced homocysteinemia?
Topics: Aged; Aged, 80 and over; Case-Control Studies; Clofibric Acid; Databases, Factual; Female; Homocyste | 2008 |